Pegues D A, Pegues C F, Hibberd P L, Ford D S, Hooper D C
Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston 02114-2696, USA.
J Clin Microbiol. 1997 Jun;35(6):1565-70. doi: 10.1128/jcm.35.6.1565-1570.1997.
We prospectively identified patients at the Massachusetts General Hospital from whom vancomycin-resistant enterococci (VRE) were isolated from a clinical specimen from 1 January 1991 through 31 December 1995. VRE strains were available from 139 (82%) of the 169 patients with clinical cases. Of these, 39 (28%) were identical or closely related by pulsed-field gel electrophoresis (i.e., VRE type A strain), including 38 (43%) of 89 VRE strains in 1995. By multivariate analysis, acquisition of the VRE type A strain was associated with receipt of clindamycin (odds ratio [OR] = 10.5), 15 or more days of hospitalization before the first isolation of VRE (OR = 2.9), and residence on one of the general medical floors (OR = 7.8). The VRE type A strain was a vanA strain of Enterococcus faecium and was highly resistant to all antimicrobial agents tested except chloramphenicol. These findings document the rapid dissemination of a highly resistant strain of E. faecium among patients and among other extant VRE strains at the Massachusetts General Hospital in 1995.
我们前瞻性地确定了1991年1月1日至1995年12月31日期间在马萨诸塞州总医院临床标本中分离出耐万古霉素肠球菌(VRE)的患者。169例临床病例中有139例(82%)可获得VRE菌株。其中,39例(28%)通过脉冲场凝胶电泳鉴定为相同或密切相关(即VRE A型菌株),包括1995年89株VRE菌株中的38株(43%)。多因素分析显示,获得VRE A型菌株与使用克林霉素相关(比值比[OR]=10.5)、首次分离出VRE前住院15天或更长时间(OR=2.9)以及住在普通内科病房之一(OR=7.8)。VRE A型菌株是粪肠球菌的vanA菌株,除氯霉素外,对所有测试抗菌药物均高度耐药。这些发现证明了1995年在马萨诸塞州总医院,一种高耐药性粪肠球菌菌株在患者之间以及在其他现存VRE菌株中迅速传播。